首页> 外文期刊>Journal of Cell Biology and Genetics >Molecular characterization of fusion transcripts in prostate cancer patients: A tool having diagnostic implications in Pakistan
【24h】

Molecular characterization of fusion transcripts in prostate cancer patients: A tool having diagnostic implications in Pakistan

机译:前列腺癌患者融合转录本的分子表征:在巴基斯坦具有诊断意义的工具

获取原文
       

摘要

Substantial fraction of information has been added with reference to fusion transcripts in hematological malignancies. However these fusion transcripts have been characterized in epithelial cells of prostate and are documented to gear up the process of neoplasia. TMPRSS2-ERG and related transcripts are key offenders in the subversion of core biological systems driving oncogenic transformation. In an RT PCR based study, 90 samples of tissue specimen of prostate cancer patients and 20 “prostate cancer negative” tissue specimens from different hospitals of Lahore and Islamabad were analyzed. There was a prevalence of atleast one isoform in 65 patients. There is no pre-existing accurate and precise assay to determine or evaluate the aggressiveness of prostate cancer in Pakistan. This study underscores that prostate cancer tissue specimen harbor hormonally regulated TMPRSS2-ERG and NDRG1-ERG fusions. This study represents a different approach in the clinical management of prostate cancer in Pakistan. It has to be included in diagnosis and prognosis to improve the treatment of prostate cancer. It seems pragmatic that PSA based evaluations do not guarantee a proper and scrutinized analysis of prostate cancer patients.
机译:参考血液恶性肿瘤中的融合转录本,已添加了大量信息。然而,这些融合转录本已在前列腺上皮细胞中表征,并被证明可促进肿瘤形成。 TMPRSS2-ERG和相关转录本是颠覆驱动致癌转化的核心生物系统的主要犯罪者。在基于RT PCR的研究中,分析了来自拉合尔和伊斯兰堡不同医院的90例前列腺癌患者的组织标本和20例“前列腺癌阴性”组织标本。 65名患者中至少存在一种同工型。尚无预先确定的精确测定方法来确定或评估巴基斯坦前列腺癌的侵袭性。该研究强调前列腺癌组织标本具有激素调节的TMPRSS2-ERG和NDRG1-ERG融合体。这项研究代表了巴基斯坦前列腺癌临床管理中的另一种方法。它必须包括在诊断和预后中以改善前列腺癌的治疗。基于PSA的评估不能保证对前列腺癌患者进行适当且仔细的分析,这似乎是实用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号